Literature DB >> 28580748

Opioid addiction and misuse in adult and adolescent patients with cancer.

Ross Pinkerton1, Janet R Hardy2.   

Abstract

In the context of a therapeutic opioid epidemic, particularly in the USA, where increasingly stringent screening for 'at risk' individuals and close monitoring of opioid prescription and use is strongly recommended, the issue of misuse within the cancer population must be addressed. Most patients with advanced cancer will have pain requiring opioid therapy at some stage during their disease course. In the majority, this will provide good pain relief with no short- or longer-term adverse sequelae. A subset will present with substance misuse issues that will influence management and prescribing practice. The potential ethical issues of limiting effective analgesia on the basis of addiction risk or history must be acknowledged. Both a judgemental or 'relaxed' approach to such patients is problematic. Ignoring the situation will not be in the patient's best interest, but an undue focus on this aspect may damage therapeutic relationships with clinicians and adversely affect a holistic approach to care. Clinical practitioners must be aware of the risk factors for opioid misuse and in patients who are not under palliative care consider screening prior to commencing opioids. Clinicians must be able to manage and monitor those identified as having an opioid misuse problem.
© 2017 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28580748     DOI: 10.1111/imj.13449

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  8 in total

1.  A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial.

Authors:  Gerald Cochran; Qi Chen; Craig Field; Amy L Seybert; Valerie Hruschak; Amanda Jaber; Adam J Gordon; Ralph Tarter
Journal:  Drug Alcohol Depend       Date:  2019-10-22       Impact factor: 4.492

2.  Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.

Authors:  Andrea C Betts; Caitlin C Murphy; L Aubree Shay; Bijal A Balasubramanian; Christine Markham; Marlyn Allicock
Journal:  J Cancer Surviv       Date:  2022-01-08       Impact factor: 4.442

3.  Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.

Authors:  Mohammed M Alsultan; Jeff Jianfei Guo
Journal:  Am Health Drug Benefits       Date:  2022-03

4.  The association between advanced orthopedic certification and confidence and engagement in prescription opioid medication misuse management practices: a cross-sectional study.

Authors:  John Magel; Mark D Bishop; Elaine Lonnemann; Gerald Cochran; Julie M Fritz; Nancy West; Adam J Gordon
Journal:  J Man Manip Ther       Date:  2021-11-17

Review 5.  Stringent Control of Opioids: Sound Public Health Measures, but a Step Too Far in Palliative Care?

Authors:  Ross Pinkerton; Geoffrey Mitchell; Janet Hardy
Journal:  Curr Oncol Rep       Date:  2020-03-13       Impact factor: 5.075

6.  Pain Knowledge and Attitudes Among Nurses in Cancer Care in Norway.

Authors:  Inger Utne; Milada Cvancarova Småstuen; Ulla Nyblin
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

7.  Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors.

Authors:  Lucas K Vitzthum; Paul Riviere; Paige Sheridan; Vinit Nalawade; Rishi Deka; Timothy Furnish; Loren K Mell; Brent Rose; Mark Wallace; James D Murphy
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

8.  Palliative care for patients with substance use disorder and multiple problems: a qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience.

Authors:  Anne Ebenau; Boukje Dijkstra; Chantal Ter Huurne; Jeroen Hasselaar; Kris Vissers; Marieke Groot
Journal:  BMC Palliat Care       Date:  2020-01-14       Impact factor: 3.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.